Encapsulation of Gemcitabine on Porphyrin Aluminum Metal-Organic Framework by Mechano-Chemistry, Delayed Drug Release and Cytotoxicity to Pancreatic Cancer PANC-1 Cells.
Gemcitabine
Deoxycytidine
/ analogs & derivatives
Metal-Organic Frameworks
/ chemistry
Humans
Pancreatic Neoplasms
/ drug therapy
Cell Line, Tumor
Aluminum
/ chemistry
Drug Liberation
Delayed-Action Preparations
/ pharmacology
Porphyrins
/ chemistry
Cell Survival
/ drug effects
Antimetabolites, Antineoplastic
/ pharmacology
drug release
gemcitabine
mechano-chemistry
metal-organic framework
pancreatic cancer cells
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
04 Jul 2024
04 Jul 2024
Historique:
received:
19
05
2024
revised:
23
06
2024
accepted:
27
06
2024
medline:
13
7
2024
pubmed:
13
7
2024
entrez:
13
7
2024
Statut:
epublish
Résumé
Gemcitabine is a widely used antimetabolite drug of pyrimidine structure, which can exist as a free-base molecular form (Gem). The encapsulated forms of medicinal drugs are of interest for delayed and local drug release. We utilized, for the first time, a novel approach of mechano-chemistry by liquid-assisted grinding (LAG) to encapsulate Gem on a "matrix" of porphyrin aluminum metal-organic framework Al-MOF-TCPPH
Identifiants
pubmed: 38999141
pii: molecules29133189
doi: 10.3390/molecules29133189
pii:
doi:
Substances chimiques
Gemcitabine
0
Deoxycytidine
0W860991D6
Metal-Organic Frameworks
0
Aluminum
CPD4NFA903
Delayed-Action Preparations
0
Porphyrins
0
Antimetabolites, Antineoplastic
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : 4SC3GM136647-05S5
Pays : United States